These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 495016)

  • 1. [Inhibitory effect of kallikrein on ristocetin-induced platelet aggregation (author's transl)].
    Fukutake K; Ukita M; Kitamura T; Yamaguchi I
    Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):549-50. PubMed ID: 495016
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of kallikrein on human platelet aggregation.
    Ohde H; Mozai T; Hase M; Kitakoji J; Ninomiya F; Chung YH; Fujimoto M
    Adv Exp Med Biol; 1983; 156 (Pt B)():741-5. PubMed ID: 6305166
    [No Abstract]   [Full Text] [Related]  

  • 3. [Human factor VIII and platelet membrane glycoproteins implicated in ristocetin-induced aggregation (author's transl)].
    Niiya K; Koya H; Hayashi H; Nozaki H; Kitajima K
    Rinsho Ketsueki; 1978 Oct; 19(10):1322-31. PubMed ID: 570230
    [No Abstract]   [Full Text] [Related]  

  • 4. [von Willebrand's disease with an increased ristocetin-induced platelet aggregation and a qualitative abnormality of the factor VIII protein (author's transl)].
    Takahashi H; Oda E; Hattori A; Kobayashi I; Takahashi K; Sakuragawa N; Shibata A
    Rinsho Ketsueki; 1980 Apr; 21(4):544-54. PubMed ID: 6774131
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of sulfinpyrazone on enhanced platelet aggregation in vitro (author's transl)].
    Walter E; Weber E
    Arzneimittelforschung; 1978; 28(10):1778-81. PubMed ID: 582683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ristocetin-induced platelet aggregation in von Willebrand's disease, thrombasthenia and essential athrombia with special reference to AHF-like antigen (author's transl)].
    Ishiguro J; Kondo M; Ogata K; Takahashi T; Kamiya T
    Rinsho Ketsueki; 1975 Jul; 16(7):716-24. PubMed ID: 1080812
    [No Abstract]   [Full Text] [Related]  

  • 7. [The laboratory diagnosis of von Willebrand's disease (author's transl)].
    Niessner H
    Wien Klin Wochenschr; 1976 Apr; 88(7):221-31. PubMed ID: 1086551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma components which interfere with ristocetin-induced platelet aggregation.
    Baugh RF; Brown JE; Hougie C
    Thromb Diath Haemorrh; 1975 Jun; 33(3):540-6. PubMed ID: 1080300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of kallikrein on lung metastasis of cancer cells, and its influence on platelet aggregation].
    Kawai Y
    Nihon Gan Chiryo Gakkai Shi; 1985 May; 20(4):765-75. PubMed ID: 3850923
    [No Abstract]   [Full Text] [Related]  

  • 10. [Normal values of platelet aggregation in a Mexican population (author's transl)].
    Anaya R; Flores RM; Linares G; Alger M
    Rev Invest Clin; 1977; 29(2):127-35. PubMed ID: 897388
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of platelet aggregation by moxalactam and free N-methylthiotetrazole.
    Ingalls CS; Somani P; Freimer EH
    Clin Ther; 1989; 11(5):640-51. PubMed ID: 2629724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a new mode of defective ristocetin-induced platelet aggregation.
    Baugh RF; Hougie C
    J Lab Clin Med; 1981 Jun; 97(6):864-80. PubMed ID: 6971912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-glycosylthioureido aglyco-ristocetins without platelet aggregation activity.
    Sztaricskai F; Pintér G; Röth E; Herczegh P; Kardos S; Rozgonyi F; Boda Z
    J Antibiot (Tokyo); 2007 Aug; 60(8):529-33. PubMed ID: 17827665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers.
    Gjønnaess E; Solum NO; Brosstad F
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):395-405. PubMed ID: 1420815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ristocetin- and thrombin-induced platelet aggregation at physiological shear rates: differential roles for GPIb and GPIIb-IIIa receptor.
    Kasirer-Friede A; Frojmovic MM
    Thromb Haemost; 1998 Sep; 80(3):428-36. PubMed ID: 9759623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of ristocetin-induced platelet aggregation in patients with infective endocarditis.
    Matsumoto M; Murakami H; Matsushima T; Tamura J; Sadakata H; Narahara N; Sawamura M; Naruse T; Tsuchiya J
    J Int Med Res; 1994; 22(1):63-6. PubMed ID: 8187946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Variations in quantitative ristocetin platelet aggregation (RPA) with time after platelet rich plasma (PRP) preparation: association with alteration in pH.
    Coller BS; Gralnick HR
    Thromb Diath Haemorrh; 1975 Nov; 34(2):581-2. PubMed ID: 809
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo effect of losartan on platelet aggregation in patients with hypertension.
    Akdemir R; Ozhan H; Yazici M; Gunduz H; Duran S; Gurel C; Ozdas S; Uyan C; Basar I; Ulutin T
    Heart Vessels; 2004 Jul; 19(4):167-71. PubMed ID: 15278389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralization of the local negative charge carried by glycoprotein (GP)-Ib in ristocetin-induced platelet agglutination.
    Tanoue K; Jung SM; Yamamoto N; Yamazaki H
    Thromb Haemost; 1984 Feb; 51(1):79-83. PubMed ID: 6232731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A monoclonal antibody to the surface membrane of human platelets which inhibits ristocetin- and collagen-induced platelet aggregation reacts with H1 histones of cell nuclei.
    Cosgrove L; Alderuccio F; Toh BH; Pedersen J; Holliday A; McKenzie I
    Clin Exp Immunol; 1987 Aug; 69(2):409-19. PubMed ID: 3308229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.